These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31275056)

  • 1. Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis.
    Li J; Zhao X; Li X; Lu M; Zhang H
    Mediators Inflamm; 2019; 2019():2136501. PubMed ID: 31275056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin vs. Fecal Immunochemical Test: A Systematic Review and Meta-analysis.
    Hu T; Zhang Z; Song F; Zhang W; Yang J
    Turk J Gastroenterol; 2023 Sep; 34(9):892-901. PubMed ID: 37427885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta-analysis.
    Dai C; Jiang M; Sun MJ; Cao Q
    J Gastroenterol Hepatol; 2018 May; 33(5):990-997. PubMed ID: 29427297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.
    Mao R; Xiao YL; Gao X; Chen BL; He Y; Yang L; Hu PJ; Chen MH
    Inflamm Bowel Dis; 2012 Oct; 18(10):1894-9. PubMed ID: 22238138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
    Kawashima K; Oshima N; Kishimoto K; Kataoka M; Fukunaga M; Kotani S; Sonoyama H; Oka A; Mishima Y; Kazumori H; Ishikawa N; Araki A; Ishihara S
    Inflamm Bowel Dis; 2023 Mar; 29(3):359-366. PubMed ID: 35583193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study.
    Kim ES; Lee HS; Kim SK; Kim EY; Jang BI; Kim KO; Yang CH; Lee YJ;
    Scand J Gastroenterol; 2020 Feb; 55(2):163-168. PubMed ID: 31984815
    [No Abstract]   [Full Text] [Related]  

  • 8. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
    Rokkas T; Portincasa P; Koutroubakis IE
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):299-306. PubMed ID: 30240474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.
    Gisbert JP; Bermejo F; Pérez-Calle JL; Taxonera C; Vera I; McNicholl AG; Algaba A; López P; López-Palacios N; Calvo M; González-Lama Y; Carneros JA; Velasco M; Maté J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1190-8. PubMed ID: 19291780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
    J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Patel A; Panchal H; Dubinsky MC
    Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous Measurements of Faecal Calprotectin and the Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Stratify Risk of Relapse.
    Nakarai A; Hiraoka S; Takahashi S; Inaba T; Higashi R; Mizuno M; Takashima S; Inokuchi T; Sugihara Y; Takahara M; Harada K; Kato J; Okada H
    J Crohns Colitis; 2018 Jan; 12(1):71-76. PubMed ID: 28961792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Calprotectin in Predicting Relapse of Inflammatory Bowel Disease in Children and Adolescents: A Meta-Analysis and Systematic Review.
    Hu T; Wang W; Song F; Zhang W; Yang J
    Pediatr Ann; 2023 Sep; 52(9):e357-e362. PubMed ID: 37695282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy.
    Yamamoto T; Shiraki M; Bamba T; Umegae S; Matsumoto K
    Int J Colorectal Dis; 2014 Apr; 29(4):485-91. PubMed ID: 24343276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.
    Garcia-Planella E; Mañosa M; Chaparro M; Beltrán B; Barreiro-de-Acosta M; Gordillo J; Ricart E; Bermejo F; García-Sánchez V; Piqueras M; Llaó J; Gisbert JP; Cabré E; Domènech E;
    Scand J Gastroenterol; 2018 Feb; 53(2):152-157. PubMed ID: 29189092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
    Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
    J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: faecal calprotectin and histologic remission in ulcerative colitis.
    D'Amico F; Bonovas S; Danese S; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2020 Apr; 51(7):689-698. PubMed ID: 32048751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis.
    Lobatón T; Rodríguez-Moranta F; Lopez A; Sánchez E; Rodríguez-Alonso L; Guardiola J
    Inflamm Bowel Dis; 2013 Apr; 19(5):1034-42. PubMed ID: 23470502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.